Heterozygous splice mutation inPIK3R1causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterozygous splice mutation inPIK3R1causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 211, Issue 13, Pages 2537-2547
Publisher
Rockefeller University Press
Online
2014-12-09
DOI
10.1084/jem.20141759
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical delineation and natural history of thePIK3CA-related overgrowth spectrum
- (2014) Kim M. Keppler-Noreuil et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110 , for relapsed/refractory chronic lymphocytic leukemia
- (2014) J. R. Brown et al. BLOOD
- Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase- , as therapy for previously treated indolent non-Hodgkin lymphoma
- (2014) I. W. Flinn et al. BLOOD
- A phase 1 study of the PI3K inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
- (2014) B. S. Kahl et al. BLOOD
- Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome
- (2014) Clea Bárcena et al. BMC Medical Genetics
- Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome
- (2014) Sven Kracker et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mutations in PIK3CD Can Cause Hyper IgM Syndrome (HIGM) Associated with Increased Cancer Susceptibility
- (2014) M. C. Crank et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A human immunodeficiency caused by mutations in the PIK3R1 gene
- (2014) Marie-Céline Deau et al. JOURNAL OF CLINICAL INVESTIGATION
- Idelalisib: targeting PI3Kδ in B-cell malignancies
- (2014) Judith A Gilbert LANCET ONCOLOGY
- PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy
- (2013) Christel Thauvin-Robinet et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mutations in PIK3R1 Cause SHORT Syndrome
- (2013) David A. Dyment et al. AMERICAN JOURNAL OF HUMAN GENETICS
- SHORT Syndrome with Partial Lipodystrophy Due to Impaired Phosphatidylinositol 3 Kinase Signaling
- (2013) Kishan Kumar Chudasama et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency
- (2013) Carrie L Lucas et al. NATURE IMMUNOLOGY
- Phosphoinositide 3-Kinase Gene Mutation Predisposes to Respiratory Infection and Airway Damage
- (2013) I. Angulo et al. SCIENCE
- Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K
- (2012) Mary Ellen Conley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
- (2012) Marjorie J Lindhurst et al. NATURE GENETICS
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
- (2012) Jean-Baptiste Rivière et al. NATURE GENETICS
- De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
- (2012) Jeong Ho Lee et al. NATURE GENETICS
- PIK3R1 (p85 ) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
- (2011) M. E. Urick et al. CANCER RESEARCH
- Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α
- (2011) John E. Burke et al. STRUCTURE
- CAL-101, a p110 selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
- (2010) B. J. Lannutti et al. BLOOD
- Cancer-derived mutations in the regulatory subunit p85 of phosphoinositide 3-kinase function through the catalytic subunit p110
- (2010) M. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
- (2009) Bijay S. Jaiswal et al. CANCER CELL
- Targeting the PI3K signaling pathway in cancer
- (2009) Kwok-Kin Wong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started